Showing results (271-280 of 323) with videos related to
Sort By:
Pageof 33
Arthritis and Rheumatism|February 23, 2012
Immunosuppressants reduce venous thrombosis relapse in Behçet's diseaseA C Desbois, B Wechsler, M Resche-Rigon, et al.Ocular Immunology and Inflammation|May 25, 2017
Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot StudyC Bottin, A Fel, N Butel, et al.Arthritis and Rheumatism|October 11, 2001
Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemiaP Cacoub, C Renou, G Kerr, et al.Epidemiology and Infection|April 9, 2005
Management of chronic hepatitis C in French departments of internal medicine and infectious diseasesP Cacoub, I Goderel, P Morlat, et al.AIDS Care|June 13, 2013
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study)E Rosenthal, L Piroth, E Cua, et al.Arthritis Care & Research|July 29, 2010
Azathioprine in severe uveitis of Behçet's diseaseD Saadoun, B Wechsler, C Terrada, et al.Gastroenterologie Clinique Et Biologique|June 29, 2010
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measureT Poynard, M Munteanu, Y Ngo, et al.The Journal of Antimicrobial Chemotherapy|October 19, 2017
Predictors of antimalarial self-medication in illegal gold miners in French Guiana: a pathway towards artemisinin resistanceM Douine, Y Lazrek, D Blanchet, et al.Clinical and Experimental Immunology|March 8, 2002
Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemiaG Kaplanski, V Marin, T Maisonobe, et al.Atherosclerosis|December 5, 2008
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryPatrice P Cacoub, Maria Teresa B Abola, Iris Baumgartner, et al.Pageof 33